GUJTERC

Gujarat Terce Laboratories Ltd.

BSE: 524314

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

39.30+2.2 (+5.93%)

12 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

30.62

P/E (TTM)

13.91

P/B

3.15

P/S (TTM)

0.67

EV/EBITDA

7.39

CAPE (5Y)

ROE (TTM)

27.17

ROCE (TTM)

36.06

ROA (TTM)

9.29

Avg 3Y ROE

5.42

Earnings 3Y CAGR

Sales 3Y CAGR

-1.74

Sales 5Y CAGR

8.65

Debt/Equity

0.13

Consensus TP

Strong Buy %

Promoter Holding

40.03

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Gujarat Terce Laboratories Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 13.91 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -53.01%

What is P/E Ratio?

Median: 29.6

Value 13.91

0.33286.35

High and improving ROE

The company reported strong ROE of 27.17% for 12-month ended 30 Jun 2026 and ROE improved by 4158 bps from 1 year ago

What is ROE (FY)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.13 as on 30 Jun 2026 and Debt to Equity decreased marginally by 0.02 in the last 1 year

What is Debt to Equity?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Low but stable operating margin

The company reported low operating margin of 7.0% for 12-month ended 30 Jun 2026 and operating margin improved marginally by 9 bps from 1 year ago

What is Operating profit margin?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of -7.2% for 12-month ended 30 Jun 2026 and the growth was 19.28 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 12.08

Value -7.2

-42.894040.18

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Gujarat Terce Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Gujarat Terce Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Gujarat Terce Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	35.67	35.67	35.74	35.74	35.74	35.85	36.22	36.22	36.22	36.22	36.22	36.22	36.45	36.65	36.78	37.01	37.03	37.03	37.03	37.03	37.03	37.03	37.03	40.03	40.03	40.03
Indian Promoter	35.67	35.67	35.74	35.74	35.74	35.85	36.22	36.22	36.22	36.22	36.22	36.22	36.45	36.65	36.78	37.01	37.03	37.03	37.03	37.03	37.03	37.03	37.03	40.03	40.03	40.03
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	-	0.00	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	64.33	64.33	64.26	64.26	64.26	64.15	63.78	63.78	63.78	63.78	63.78	63.78	63.55	63.35	63.22	62.99	62.97	62.97	62.97	62.97	62.97	62.97	62.97	59.97	59.97	59.97
Bodies Corporate	0.65	0.65	0.65	0.65	0.66	0.66	0.63	0.89	0.63	0.43	0.77	0.64	0.62	1.18	1.16	0.84	1.18	1.24	1.37	1.41	1.44	1.50	1.87	1.74	1.71	1.74
Others (incl. Retail) No. of shareholders	63.68 13,362	63.68 13,367	63.61 13,341	63.61 13,317	63.60 13,265	63.49 13,291	63.15 13,248	62.89 13,291	63.15 13,378	63.35 13,641	63.01 13,570	63.14 13,597	62.93 13,553	62.17 13,469	62.06 13,375	62.15 13,298	61.79 13,175	61.73 13,366	61.60 13,509	61.56 13,682	61.53 13,735	61.47 13,772	61.10 13,778	58.23 13,772	58.26 13,718	58.23 13,722

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Gujarat Terce Laboratories Ltd. is not part of any tracked index.

Prominent Investor Holdings

Dheeraj Kumar Lohia and Associates

Jun 2026

1.04%

₹ 0 Cr

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Gujarat Terce Laboratories Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Natwarbhai Prajapati Promoter & Director	February-2024	Market Purchase (Acquisition) 17th Feb 2024	8.39 %	₹ 28.00	12.05 k	₹ 3.38 lac
Natwarbhai Prajapati Promoter & Director	November-2023	Market Purchase (Acquisition) 28th Nov 2023	8.33 %	₹ 26.42	4.50 k	₹ 1.19 lac
Natwarbhai Prajapati Promoter & Director	November-2023	Market Purchase (Acquisition) 17th Nov 2023	8.32 %	₹ 23.00	998.00	₹ 22.95 k
Aalap Prajapati Promoter & Director	September-2023	Market Purchase (Acquisition) 29th Sep 2023	0.65 %	₹ 26.02	5.75 k	₹ 1.50 lac
Natwarbhai Prajapati Promoter & Director	September-2023	Market Purchase (Acquisition) 29th Sep 2023	8.28 %	₹ 23.89	3.00 k	₹ 71.67 k
Natwarbhai Prajapati Promoter & Director	September-2023	Market Purchase (Acquisition) 15th Sep 2023	8.27 %	₹ 20.00	1.08 k	₹ 21.70 k
Natwarbhai Prajapati Promoter & Director	June-2023	Market Purchase (Acquisition) 13th Jun 2023	8.14 %	₹ 27.89	9.60 k	₹ 2.68 lac
Natwarbhai Prajapati Promoter & Director	June-2023	Market Purchase (Acquisition) 2nd Jun 2023	8.12 %	₹ 21.35	1.30 k	₹ 27.76 k
Natwarbhai Prajapati Promoter & Director	June-2023	Market Purchase (Acquisition) 1st Jun 2023	8.08 %	₹ 21.61	3.60 k	₹ 77.79 k
Natwarbhai Prajapati Promoter	May-2023	Market Purchase (Acquisition) 25th May 2023	8.06 %	₹ 17.23	1.10 k	₹ 18.95 k

No corporate action data available.

Company Profile

Overview of Gujarat Terce Laboratories Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Gujarat Terce Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of medicines and healthcare products. Its product basket includes branded as well as generic formulations offering solutions fo...

Key personnel

Mr. Bhagirath R. Maurya

Chief Financial Officer

Ms. Ashka Solanki

Compliance Officer, Company Secretary

Mr. Natwarbhai P. PrajapatiD

Executive Chairman of the Board

Mr. Aalap PrajapatiD

Chief Executive Officer, Managing Director, Whole-Time Director

Mr. Amritbhai P. PrajapatiD

Whole-Time Director

Avanivishnubhai PatelD

Additional Director

Shri. Viplav Suryakantbhai KhamarD

Non-Executive Independent Director

Mr. Surendra Kumar SharmaD

Non-Executive Independent Director

View all

Incorporated on

28 Mar 1985

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

234

IPO date

28 Jan 1993

Free Float

43,10,376

Website

https://www.gujaratterce.in/

Phone no.

+917966633700

Address

D/ 801 - 802 & 1202, The First, Behind, Keshavbaug party plot, Near Shivalik High-, Street, Vastrapur,, AHMEDABAD, 380015, India

Frequently Asked Questions

What is the current share price of Gujarat Terce Laboratories Ltd.?

The current share price of Gujarat Terce Laboratories Ltd. is ₹ 39.30 as of 12 Aug 2026.

What is the market capitalisation of Gujarat Terce Laboratories Ltd.?

The market capitalisation of Gujarat Terce Laboratories Ltd. stands at ₹ 30.62 Cr.

What is the PE ratio of Gujarat Terce Laboratories Ltd.?

The Price-to-Earnings (PE) ratio of Gujarat Terce Laboratories Ltd. is 13.91 as of the latest trailing twelve months data.

What is the ROE and ROCE of Gujarat Terce Laboratories Ltd.?

Gujarat Terce Laboratories Ltd. has a Return on Equity (ROE) of 27.17% and a Return on Capital Employed (ROCE) of 36.06% as per the latest financial reports.

What is the 52-week high and low of Gujarat Terce Laboratories Ltd.?

The 52-week high of Gujarat Terce Laboratories Ltd. is - and the 52-week low is -.

What is the dividend yield of Gujarat Terce Laboratories Ltd.?

The dividend yield of Gujarat Terce Laboratories Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Gujarat Terce Laboratories Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 58.23% of Gujarat Terce Laboratories Ltd. shares.

What sector does Gujarat Terce Laboratories Ltd. belong to?

Gujarat Terce Laboratories Ltd. operates in the Healthcare sector.

What is the beta of Gujarat Terce Laboratories Ltd.?

The beta of Gujarat Terce Laboratories Ltd. is 0.71, indicating its price volatility relative to the broader market. Over the past 1 year, Gujarat Terce Laboratories Ltd. has delivered an absolute return of -20.36%.

What is the RSI of Gujarat Terce Laboratories Ltd.?

The 14-day Relative Strength Index (RSI) of Gujarat Terce Laboratories Ltd. is 54.91, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Gujarat Terce Laboratories Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Gujarat Terce Laboratories Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Stock Analysis

Holdings and Presence

Company Profile